Top Safety Accreditation for Extract Technology Ltd
International business Extract Technology has been awarded accreditation from Safecontractor for its commitment to achieving excellence in health and safety.
Safecontractor is a leading third party accreditation scheme which recognises very high standards in health and safety management amongst UK companies.
Employing 65 people in Huddersfield, Extract Technology is principally involved in the life science sector, specialising in the containment and aseptic solutions for the pharmaceutical and biotech industries. Extract Technology’s most recent clients have included major players such as GlaxoSmithKline, Astra Zeneca, TEVA and Sandoz.
The company’s application for Safecontractor accreditation was driven by the need for a uniform standard across the business.
General Manager Alan Wainwright commented: “I would like to thank all those involved for their hard work in helping to achieve the standard. To gain accreditation to the scheme is another important achievement for our business and clearly demonstrates our commitment to health and safety within our organisation. Safecontractor accreditation not only supports our overall health and safety management practices but will enhance the company’s ability to attract new contracts.”
John Kinge, Technical Director of Safecontractor said: "Major organisations simply cannot afford to run the risk of employing contractors who are not able to prove that they have sound health and safety policies in place."
"More companies need to understand the importance of adopting good risk management in the way that Extract Technology has done. The firm’s high standard has set an example which hopefully will be followed by other companies within the sector.
Safecontractor plays a vital role in supporting our clients in meeting their compliance needs, whilst working with their contractors as they progress through the accreditation process.”
Under the Safecontractor scheme, businesses undergo a vetting process which examines health and safety procedures and their track record for safe practice. Those companies meeting the high standard are included on a database, which is accessible to registered users only via a website.
Client-organisations who sign up to the scheme can access the database, enabling them to audit potential contractors before they attend site. These clients agree that, as users of the scheme, they will engage only those who have received accreditation.
Over 210 major, nation-wide businesses, from several key sectors, have signed up to use the scheme when selecting contractors for services such as building, cleaning, maintenance, refurbishment or electrical and mechanical work.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance